Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TARS
#1652
Tarsus Pharmaceuticals, Inc. Common Stock
73.810
0
USD
+1.60%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.60%
Monthly Change
+7.74%
6 month change
+11.73%
Year Change
+11.73%
Previous Close
72.650
0
Open
73.810
0
Bid
Ask
Low
73.810
0
High
73.810
0
Volume
41
Markets
US Stock Market
Healthcare
TARS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
20.5 M
20.71 M
26.73 M
34.22 M
38.38 M
42.56 M
—
Valuation ratios
Enterprise value
679.26 M
294.62 M
334.13 M
496.64 M
2.1 B
3.38 B
9.62 B
Price to earnings ratio
—
-33.58
-5.72
-4.36
-18.04
-51.5
-118
Price to sales ratio
—
8.11
13.75
33.95
11.38
7.58
28.09
Price to cash flow ratio
—
123.39
-7.24
-5.04
-25.08
-274.78
-367.61
Price to book ratio
—
2.77
1.84
3.01
9.27
9.96
15.19
Enterprise value to EBITDA ratio
-25.34
-25.52
-4.97
-3.2
-16.5
-44.58
-104.72
Profitability ratios
Return on assets %
-0.16
-0.08
-0.27
-0.51
-0.31
-0.12
-0.13
Return on equity %
-0.16
-0.08
-0.32
-0.69
-0.51
-0.19
-0.2
Return on invested capital %
-1 906.71
-566.25
-2 112.36
-2 838.11
-1 840.82
-617.61
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-21.32
-242.92
-820.53
-65.9
-15.72
-72.66
EBITDA margin %
—
-20.24
-244.4
-831.43
-67.27
-16.4
-75.25
Net margin %
—
-24.25
-240.51
-778.89
-63.16
-14.72
-68
Liquidity ratios
Quick ratio
—
—
—
6.85
4.39
3.82
18.83
Current ratio
31.68
15.33
14.61
6.93
4.42
3.85
18.97
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.33
0.13
0.07
0.57
0.96
0.89
Solvency ratios
Debt to assets ratio
—
—
0.09
0.12
0.19
0.15
0.59
Debt to equity ratio
—
—
0.11
0.16
0.32
0.24
0.92
Long term debt to total assets ratio
—
—
0.09
0.11
0.19
0.13
0.55
Long term debt to total equity ratio
—
—
0.1
0.15
0.32
0.21
0.85
Per share metrics
Operating cash flow per share
—
0.18
-1.99
-4
-2.21
-0.3
-0.33
EBIT per share
—
-0.59
-2.55
-4.87
-3.21
-1.7
-1.72
EBITDA per share
—
-0.56
-2.56
-4.94
-3.27
-1.77
-1.78
Total debt per share
—
—
0.83
1.08
1.93
1.99
7.47
Cash per share
—
8.36
8.82
7.74
7.75
9.99
38.78
Net current asset value per share
—
8.56
9.15
8.72
9.49
12.51
47.71
Tangible book value per share
—
8.11
7.84
6.57
5.75
8.04
31.89
Working capital per share
—
8
8.53
7.46
7.34
9.26
37.39
Book value per share
—
8.11
7.84
6.7
5.97
8.22
32.64
News
Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses (NASDAQ:TARS)
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating
Cloudflare Qualifies For Two Top Stock Lists, Leads 13 Newcomers To IBD 50, Stock Spotlight, More
Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges
Tarsus Pharma COO Neervannan Seshadri sells $641k in stock
Tarsus Pharmaceuticals at TD Cowen Conference: Eyeing Blockbuster Growth
Maker Of Eye Drops Has Sights On Buy Point
Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens
Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders